Ceren Ozek

Ceren Ozek, PhD, is a seasoned researcher currently serving as a Senior Research Investigator at Isomorphic Labs since December 2023. Prior to this role, Ceren held positions at BenevolentAI as a Senior Drug Discovery Scientist and Biology Project Leader, where leadership in the biology strategy for Parkinson's Disease discovery programs and involvement in target identification were key contributions. Experience also includes serving as a Senior Research Scientist at MiNA Therapeutics, focusing on collaborations related to metabolic diseases, as well as extensive postdoctoral research at Harvard University under Dr. Lee Rubin. Ceren completed a PhD in Neuroscience at the University of Pennsylvania, exploring BDNF/TrkB signaling related to metabolic diseases and previous engagement in summer research internships at prestigious institutions like Harvard and Yale. Ongoing education includes participation in Harvard Medical School's HMX Pro Fundamentals Pharmacology Essentials program.